CN Patent

CN114137133B — 一种纳洛醇-peg衍生物有关物质的检测方法

Assigned to Beijing Shangxiutang Pharmaceutical Technology Co ltd · Expires 2023-06-09 · 3y expired

What this patent protects

本发明提供了一种测定纳洛醇‑PEG衍生物及其制剂有关物质的分析方法,该方法采用反相高效液相色谱法,采用极性硅胶或等效柱,流动相为水‑乙腈溶液、水‑甲醇溶液或水‑乙腈‑甲醇溶液,并包含了添加剂。采用外标法或加校正因子的主成分对照法定量测定纳洛醇‑PEG衍生物及其制剂中已知杂质的含量,采用主成分自身对照法测定未知杂质含量。该方法主峰与各杂质峰之间的分离度均大于2.0,灵敏度高,耐用性好,可较好控制产品质量。

USPTO Abstract

本发明提供了一种测定纳洛醇‑PEG衍生物及其制剂有关物质的分析方法,该方法采用反相高效液相色谱法,采用极性硅胶或等效柱,流动相为水‑乙腈溶液、水‑甲醇溶液或水‑乙腈‑甲醇溶液,并包含了添加剂。采用外标法或加校正因子的主成分对照法定量测定纳洛醇‑PEG衍生物及其制剂中已知杂质的含量,采用主成分自身对照法测定未知杂质含量。该方法主峰与各杂质峰之间的分离度均大于2.0,灵敏度高,耐用性好,可较好控制产品质量。

Drugs covered by this patent

Patent Metadata

Patent number
CN114137133B
Jurisdiction
CN
Classification
Expires
2023-06-09
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Shangxiutang Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.